化学试剂

Search documents
西陇科学中标:中石化(大连)石油化工研究院有限公司化学试剂20250723询比采购采购结果公告
Sou Hu Cai Jing· 2025-08-26 05:17
通过天眼查大数据分析,西陇科学股份有限公司共对外投资了26家企业,参与招投标项目1658次;财产 线索方面有商标信息298条,专利信息90条,著作权信息10条;此外企业还拥有行政许可60个。 数据来源:天眼查APP 证券之星消息,根据天眼查APP-财产线索数据整理,根据中石化(大连)石油化工研究院有限公司月8 日24发布的《中石化(大连)石油化工研究院有限公司化学试剂20250723询比采购采购结果公告》内容 显示,西陇科学股份有限公司中标,详情如下: 标题:中石化(大连)石油化工研究院有限公司化学试剂20250723询比采购采购结果公告 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 采购方:中石化(大连)石油化工研究院有限公司 供应商:西陇科学股份有限公司 中标金额: 地区:辽宁省 发布日期:2025-08-24 ...
2025年中国化学试剂行业发展历程、产业链、市场规模、竞争格局及发展趋势研判:市场规模将达2600亿元,市场对高性能化学试剂的需求日益增加[图]
Chan Ye Xin Xi Wang· 2025-08-10 00:36
Core Viewpoint - The development of China's chemical reagent industry has evolved from reliance on imports to gradual self-sufficiency, transitioning from low-end general reagents to high-end specialized reagents, with significant growth projected in market size [1][8]. Group 1: Industry Definition and Classification - Chemical reagents are refined fine chemical products derived from industrial-grade chemicals, classified by usage into general chemical reagents, PCB chemical reagents, and ultra-pure reagents, and by purity levels ranging from experimental pure (≥90%) to high purity (≥99.99%) [2][10]. Group 2: Current Development Status - The chemical reagent industry in China has undergone five stages: initial stage, developmental stage, reform and opening-up stage, rapid development stage, and mature development stage, with the current market becoming increasingly competitive [5][7]. Group 3: Market Size and Growth - The market size of China's chemical reagent industry is expected to grow to 240 billion yuan in 2024, an increase of 18.6 billion yuan from 2023, and is projected to reach 260 billion yuan by 2025 [1][8]. Group 4: Industry Chain - The chemical reagent industry is a crucial branch of laboratory supplies and fine chemicals, with the upstream including chemical raw materials, packaging materials, and equipment; the midstream focusing on research and production; and the downstream applications spanning various fields such as pharmaceuticals, new materials, and environmental protection [10][12]. Group 5: Competitive Landscape - The global chemical reagent market is dominated by foreign companies, with major players including Sigma-Aldrich, Thermo Fisher Scientific, and Cayman Chemical, which collectively hold over 80% of the market share in China's research reagent market [14][15]. Group 6: Development Trends - The industry is experiencing transformation driven by technological advancements, with increasing demand for high-performance chemical reagents, particularly in the fields of biotechnology, pharmaceuticals, electronics, and new energy [18][19][20]. - Environmental sustainability is becoming a key trend, prompting the development of green chemical reagents that meet environmental standards [18].
西陇科学实控人之一黄少群累计质押3339万股,公司此前被处罚正面临股民维权
Sou Hu Cai Jing· 2025-08-08 02:41
Core Viewpoint - West Long Science Co., Ltd. announced the release and new pledge of shares by its actual controller, Huang Shaoqun, indicating personal funding needs while emphasizing that this will not adversely affect the company's operations or governance [3][4]. Group 1: Share Pledge Details - Huang Shaoqun released 10,250,000 shares, accounting for 18.14% of his holdings and 1.75% of the company's total share capital, with the release date set for August 6, 2025 [3]. - He also pledged 10,860,000 shares, representing 19.22% of his holdings and 1.86% of the company's total share capital, starting from August 6, 2025 [3]. - As of the announcement date, Huang Shaoqun had a total of 33,390,000 shares pledged, with the cumulative pledge by him and his concerted actors accounting for 34.50% of his holdings and 8.83% of the company's total share capital [3]. Group 2: Regulatory Issues - On July 7, 2023, West Long Science received an administrative penalty from the Guangdong Securities Regulatory Bureau for information disclosure violations, resulting in a fine of 1.2 million yuan [4]. - The company was found to have inflated revenue and profits through fictitious trading activities involving ethylene glycol and methanol [4]. - Huang Shaoqun and other executives received individual fines ranging from 50,000 to 800,000 yuan for their roles in the violations [4]. Group 3: Company Overview and Financial Performance - West Long Science was established on July 19, 1994, with a registered capital of 5.852 billion yuan, focusing on the R&D, production, and sales of chemical reagents and raw materials [5][6]. - The company reported revenues of 6.183 billion yuan, 7.092 billion yuan, and 7.816 billion yuan for 2022 to 2024, reflecting year-on-year growth rates of 14.93%, 24.42%, and 10.22% respectively [6]. - The net profit attributable to shareholders for the same period was 88.05 million yuan, 33.35 million yuan, and 61.77 million yuan, with year-on-year changes of -52.93%, -62.56%, and 85.24% respectively [6]. - The company's asset-liability ratios were 53.46%, 50.64%, and 51.10% for the years 2022 to 2024 [6].
阿拉丁:阿拉转债自2025年5月28日起停止转股
news flash· 2025-05-22 08:47
Group 1 - The company will announce the implementation of equity distribution and the adjustment of the conversion price for "Aladdin Convertible Bonds" on May 29, 2025 [1] - From May 28, 2025, until the equity distribution registration date, the "Aladdin Convertible Bonds" will suspend conversion, and conversion will resume on the first trading day after the registration date [1] - The profit distribution plan for the year 2024 includes a cash dividend of 1 yuan (before tax) for every 10 shares and a capital reserve increase of 2 shares for every 10 shares [1]
上海泰坦科技股份有限公司关于自愿披露子公司研发生产成功金标色谱级溶剂的公告
Shang Hai Zheng Quan Bao· 2025-04-15 21:55
Group 1 - The company has successfully developed and produced a gold standard chromatographic solvent through upgrading its existing high-purity solvent production process, achieving significant reductions in metal ion content to the sub-ppb level and organic trace impurities to below 5 ppt [1][2] - The new solvent has been tested internally and meets or exceeds the performance indicators of imported brands from the US and Europe, demonstrating comparable or superior results in various analytical applications [2] - The product is primarily used in fields such as life sciences, pharmaceutical research, trace organic detection, food and drug safety testing, and environmental pollution detection [2] Group 2 - The successful development of the gold standard chromatographic solvent enriches the company's series of chromatographic chemicals and has led to preliminary bulk orders from domestic customers, which is expected to positively impact market expansion and performance growth [3]
昊帆生物:首次公开发行股票并在创业板上市招股说明书
2023-07-06 12:42
本次发行股票拟在创业板上市,创业板公司具有创新投入大、新旧产业融合 存在不确定性、尚处于成长期、经营风险高、业绩不稳定、退市风险高等特 点,投资者面临较大的市场风险。投资者应充分了解创业板的投资风险及本 公司所披露的风险因素,审慎作出投资决定。 苏州昊帆生物股份有限公司 Suzhou Highfine Biotech Co., Ltd. (苏州高新区鸿禧路 32 号 F-12 标准厂房) 首次公开发行股票并在创业板上市 招股说明书 保荐人(主承销商) (中国(上海)自由贸易试验区浦明路 8 号) 苏州昊帆生物股份有限公司 招股说明书 声明 中国证监会、交易所对本次发行所作的任何决定或意见,均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证,也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定,股票依法发行后,发行人经营与收益的变化,由发 行人自行负责;投资者自主判断发行人的投资价值,自主作出投资决策,自行承 担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 苏州昊 ...